Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Edwards Lifesciences (EW) PT Raised to $217 at RBC Capital
July 24, 2019 6:47 AM EDTRBC Capital analyst Brandon Henry raised the price target on Edwards Lifesciences (NYSE: EW) to $217.00 (from $186.00) while maintaining an Outperform rating.
Big TAVR Beat; TAVR Market Accelerated In 2Q19... MoreEdwards Lifesciences (EW) PT Raised to $250 at Cowen
July 24, 2019 6:42 AM EDTCowen analyst Joshua Jennings raised the price target on Edwards Lifesciences (NYSE: EW) to $250.00 (from $210.00) while maintaining a Outperform rating.
The analyst commented, "EW printed a significant 2Q TAVR beat that will reinvigorate investor sentiment ahead of a string of anticipated back-half... More
Edwards Lifesciences (EW) Tops Q2 EPS by 5c, Offers FY and Q3 Guidance
July 23, 2019 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q2 EPS of $1.38, $0.05 better than the analyst estimate of $1.33. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.20-$5.40, versus the consensus of $5.29.... More
